Old Mission Capital LLC Eli Lilly & CO Transaction History

Old Mission Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $207,653 - $243,816	-745 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $174,844 - $217,286	745 New	745 $213,000
Q2 2020 Aug 12, 2020	SELL	$136.42 - $164.18 $316,221 - $380,569	-2,318 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $275,957 - $341,557	2,318 New	2,318 $322,000

4,011

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.